Omega-3 polyunsaturated fatty acids in cardiology
Long-chain omega-3 polyunsaturated fatty acids (ω-3 PUFA): eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) - have some important biological effects that can be used in cardiology. Long-chain omega-3 PUFA intake, in the dose of 3-4 g/d and more, decrease hypertriglyceridemia, thrombogenesi...
Saved in:
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
«SILICEA-POLIGRAF» LLC
2005-08-01
|
| Series: | Кардиоваскулярная терапия и профилактика |
| Subjects: | |
| Online Access: | https://cardiovascular.elpub.ru/jour/article/view/994 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850041411248848896 |
|---|---|
| author | N. V. Perova |
| author_facet | N. V. Perova |
| author_sort | N. V. Perova |
| collection | DOAJ |
| description | Long-chain omega-3 polyunsaturated fatty acids (ω-3 PUFA): eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) - have some important biological effects that can be used in cardiology. Long-chain omega-3 PUFA intake, in the dose of 3-4 g/d and more, decrease hypertriglyceridemia, thrombogenesis, inflammatory and immune processes, and vascular tonus. Free EPA and DHA act as structural components of cell membranes; they modify –inhibit trans-membrane ion channels; demonstrate antiarrhythmic effects; increase heart rate variability. In GISSI-Prevenzione study, among patients taking omega-3 PUFA, the incidence of combined end-point (total mortality, nonfatal myocardial infarction (MI), and stroke (S)) was lower than that in placebo group, by 15-16% (Р=0.02). Cardiovascular death risk, plus nonfatal MI and S risk, was also lower, comparing to placebo group (-20-21%; Р=0.006). The risk reduction was maximal (-45%; Р=0.0006) for sudden death; its risk was decreased as early as after 4 months of treatment. |
| format | Article |
| id | doaj-art-05ce025dee2d484abf6307bfc4dcae23 |
| institution | DOAJ |
| issn | 1728-8800 2619-0125 |
| language | Russian |
| publishDate | 2005-08-01 |
| publisher | «SILICEA-POLIGRAF» LLC |
| record_format | Article |
| series | Кардиоваскулярная терапия и профилактика |
| spelling | doaj-art-05ce025dee2d484abf6307bfc4dcae232025-08-20T02:55:48Zrus«SILICEA-POLIGRAF» LLCКардиоваскулярная терапия и профилактика1728-88002619-01252005-08-0144101107708Omega-3 polyunsaturated fatty acids in cardiologyN. V. Perova0State Research Center for Preventive Medicine, Ministry of Health of the Russian Federation, MoscowLong-chain omega-3 polyunsaturated fatty acids (ω-3 PUFA): eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) - have some important biological effects that can be used in cardiology. Long-chain omega-3 PUFA intake, in the dose of 3-4 g/d and more, decrease hypertriglyceridemia, thrombogenesis, inflammatory and immune processes, and vascular tonus. Free EPA and DHA act as structural components of cell membranes; they modify –inhibit trans-membrane ion channels; demonstrate antiarrhythmic effects; increase heart rate variability. In GISSI-Prevenzione study, among patients taking omega-3 PUFA, the incidence of combined end-point (total mortality, nonfatal myocardial infarction (MI), and stroke (S)) was lower than that in placebo group, by 15-16% (Р=0.02). Cardiovascular death risk, plus nonfatal MI and S risk, was also lower, comparing to placebo group (-20-21%; Р=0.006). The risk reduction was maximal (-45%; Р=0.0006) for sudden death; its risk was decreased as early as after 4 months of treatment.https://cardiovascular.elpub.ru/jour/article/view/994omega-3 polyunsaturated fatty acidseicosapentaenoic aciddocosahexaenoic acidomacor |
| spellingShingle | N. V. Perova Omega-3 polyunsaturated fatty acids in cardiology Кардиоваскулярная терапия и профилактика omega-3 polyunsaturated fatty acids eicosapentaenoic acid docosahexaenoic acid omacor |
| title | Omega-3 polyunsaturated fatty acids in cardiology |
| title_full | Omega-3 polyunsaturated fatty acids in cardiology |
| title_fullStr | Omega-3 polyunsaturated fatty acids in cardiology |
| title_full_unstemmed | Omega-3 polyunsaturated fatty acids in cardiology |
| title_short | Omega-3 polyunsaturated fatty acids in cardiology |
| title_sort | omega 3 polyunsaturated fatty acids in cardiology |
| topic | omega-3 polyunsaturated fatty acids eicosapentaenoic acid docosahexaenoic acid omacor |
| url | https://cardiovascular.elpub.ru/jour/article/view/994 |
| work_keys_str_mv | AT nvperova omega3polyunsaturatedfattyacidsincardiology |